世界の一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6051
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、119ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CMX-020、CA-016、DD-04107、その他）、用途別市場規模（眼科、免疫、筋肉けいれん、そう痒症、腹痛、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の市場動向
・企業の競争状況、市場シェア
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の種類別市場規模と予測2016-2027（CMX-020、CA-016、DD-04107、その他）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の用途別市場規模と予測2016-2027（眼科、免疫、筋肉けいれん、そう痒症、腹痛、その他）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の北米市場規模2016-2027（アメリカ、カナダ）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の中南米市場規模2016-2027（メキシコ、ブラジル）
・一過性受容体潜在的カチオンチャネルサブファミリーVメンバー 1の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc、Amorepacific Corp、BCN Peptides SA、Centrexion Therapeutics Corp、Daewoong Pharmaceutical Co Ltd、DoNatur GmbH、Flex Pharma Inc、Grunenthal GmbH、Kyowa Hakko Kirin Co Ltd、Medifron DBT Co Ltd、Neurim Pharmaceuticals Ltd、Pila Pharma AB、Sylentis SAU、Toray Industries Inc、Vitality Biopharma Inc）
・結論

Market Analysis and Insights: Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market.

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Scope and Market Size
Transient Receptor Potential Cation Channel Subfamily V Member 1 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CMX-020
CA-016
DD-04107
Others

Segment by Application
Ophthalmology
Immunology
Muscle Spasm
Pruritus
Abdominal Pain
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Amorepacific Corp
BCN Peptides SA
Centrexion Therapeutics Corp
Daewoong Pharmaceutical Co Ltd
DoNatur GmbH
Flex Pharma Inc
Grunenthal GmbH
Kyowa Hakko Kirin Co Ltd
Medifron DBT Co Ltd
Neurim Pharmaceuticals Ltd
Pila Pharma AB
Sylentis SAU
Toray Industries Inc
Vitality Biopharma Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CMX-020
1.2.3 CA-016
1.2.4 DD-04107
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ophthalmology
1.3.3 Immunology
1.3.4 Muscle Spasm
1.3.5 Pruritus
1.3.6 Abdominal Pain
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2016-2027)
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Regions
2.2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Share by Regions (2016-2021)
2.2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Regions (2022-2027)
2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Dynamic
2.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
2.3.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
2.3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
2.3.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue
3.1.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (2016-2021)
3.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2016-2021)
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue
3.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio
3.4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2020
3.5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Area Served
3.6 Key Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
3.7 Date of Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Type
4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Type (2016-2021)
4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2022-2027)

5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Application
5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2016-2021)
5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2016-2027)
6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
6.2.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021)
6.2.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027)
6.2.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2027)
6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
6.3.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021)
6.3.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027)
6.3.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2027)
6.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
6.4.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021)
6.4.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2016-2027)
7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
7.2.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021)
7.2.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027)
7.2.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2027)
7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
7.3.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021)
7.3.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027)
7.3.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2027)
7.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
7.4.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021)
7.4.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2016-2027)
8.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
8.2.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2027)
8.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
8.3.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2027)
8.4 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region
8.4.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2016-2027)
9.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
9.2.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021)
9.2.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027)
9.2.3 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2027)
9.3 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
9.3.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021)
9.3.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027)
9.3.3 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2027)
9.4 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
9.4.1 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021)
9.4.2 Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2016-2027)
10.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
10.2.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2027)
10.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
10.3.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2027)
10.4 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country
10.4.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.1.4 Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Amorepacific Corp
11.2.1 Amorepacific Corp Company Details
11.2.2 Amorepacific Corp Business Overview
11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.2.4 Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.2.5 Amorepacific Corp Recent Development
11.3 BCN Peptides SA
11.3.1 BCN Peptides SA Company Details
11.3.2 BCN Peptides SA Business Overview
11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.3.4 BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.3.5 BCN Peptides SA Recent Development
11.4 Centrexion Therapeutics Corp
11.4.1 Centrexion Therapeutics Corp Company Details
11.4.2 Centrexion Therapeutics Corp Business Overview
11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.4.4 Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.4.5 Centrexion Therapeutics Corp Recent Development
11.5 Daewoong Pharmaceutical Co Ltd
11.5.1 Daewoong Pharmaceutical Co Ltd Company Details
11.5.2 Daewoong Pharmaceutical Co Ltd Business Overview
11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.5.4 Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.5.5 Daewoong Pharmaceutical Co Ltd Recent Development
11.6 DoNatur GmbH
11.6.1 DoNatur GmbH Company Details
11.6.2 DoNatur GmbH Business Overview
11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.6.4 DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.6.5 DoNatur GmbH Recent Development
11.7 Flex Pharma Inc
11.7.1 Flex Pharma Inc Company Details
11.7.2 Flex Pharma Inc Business Overview
11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.7.4 Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.7.5 Flex Pharma Inc Recent Development
11.8 Grunenthal GmbH
11.8.1 Grunenthal GmbH Company Details
11.8.2 Grunenthal GmbH Business Overview
11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.8.4 Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.8.5 Grunenthal GmbH Recent Development
11.9 Kyowa Hakko Kirin Co Ltd
11.9.1 Kyowa Hakko Kirin Co Ltd Company Details
11.9.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.9.4 Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.9.5 Kyowa Hakko Kirin Co Ltd Recent Development
11.10 Medifron DBT Co Ltd
11.10.1 Medifron DBT Co Ltd Company Details
11.10.2 Medifron DBT Co Ltd Business Overview
11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.10.4 Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.10.5 Medifron DBT Co Ltd Recent Development
11.11 Neurim Pharmaceuticals Ltd
11.11.1 Neurim Pharmaceuticals Ltd Company Details
11.11.2 Neurim Pharmaceuticals Ltd Business Overview
11.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.11.4 Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.11.5 Neurim Pharmaceuticals Ltd Recent Development
11.12 Pila Pharma AB
11.12.1 Pila Pharma AB Company Details
11.12.2 Pila Pharma AB Business Overview
11.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.12.4 Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.12.5 Pila Pharma AB Recent Development
11.13 Sylentis SAU
11.13.1 Sylentis SAU Company Details
11.13.2 Sylentis SAU Business Overview
11.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.13.4 Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.13.5 Sylentis SAU Recent Development
11.14 Toray Industries Inc
11.14.1 Toray Industries Inc Company Details
11.14.2 Toray Industries Inc Business Overview
11.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.14.4 Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.14.5 Toray Industries Inc Recent Development
11.15 Vitality Biopharma Inc
11.15.1 Vitality Biopharma Inc Company Details
11.15.2 Vitality Biopharma Inc Business Overview
11.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Introduction
11.15.4 Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
11.15.5 Vitality Biopharma Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CMX-020
Table 3. Key Players of CA-016
Table 4. Key Players of DD-04107
Table 5. Key Players of Others
Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Regions (2016-2021)
Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Regions (2022-2027)
Table 12. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends
Table 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
Table 14. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
Table 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
Table 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players (2016-2021)
Table 18. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2020)
Table 19. Ranking of Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Solution and Service
Table 23. Date of Enter into Transient Receptor Potential Cation Channel Subfamily V Member 1 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2016-2021)
Table 27. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2016-2021)
Table 31. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Inc Company Details
Table 64. Amgen Inc Business Overview
Table 65. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 66. Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 67. Amgen Inc Recent Development
Table 68. Amorepacific Corp Company Details
Table 69. Amorepacific Corp Business Overview
Table 70. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 71. Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 72. Amorepacific Corp Recent Development
Table 73. BCN Peptides SA Company Details
Table 74. BCN Peptides SA Business Overview
Table 75. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 76. BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 77. BCN Peptides SA Recent Development
Table 78. Centrexion Therapeutics Corp Company Details
Table 79. Centrexion Therapeutics Corp Business Overview
Table 80. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 81. Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 82. Centrexion Therapeutics Corp Recent Development
Table 83. Daewoong Pharmaceutical Co Ltd Company Details
Table 84. Daewoong Pharmaceutical Co Ltd Business Overview
Table 85. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 86. Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 87. Daewoong Pharmaceutical Co Ltd Recent Development
Table 88. DoNatur GmbH Company Details
Table 89. DoNatur GmbH Business Overview
Table 90. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 91. DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 92. DoNatur GmbH Recent Development
Table 93. Flex Pharma Inc Company Details
Table 94. Flex Pharma Inc Business Overview
Table 95. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 96. Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 97. Flex Pharma Inc Recent Development
Table 98. Grunenthal GmbH Company Details
Table 99. Grunenthal GmbH Business Overview
Table 100. Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 101. Grunenthal GmbH Recent Development
Table 102. Kyowa Hakko Kirin Co Ltd Company Details
Table 103. Kyowa Hakko Kirin Co Ltd Business Overview
Table 104. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 105. Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 106. Kyowa Hakko Kirin Co Ltd Recent Development
Table 107. Medifron DBT Co Ltd Company Details
Table 108. Medifron DBT Co Ltd Business Overview
Table 109. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 110. Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 111. Medifron DBT Co Ltd Recent Development
Table 112. Neurim Pharmaceuticals Ltd Company Details
Table 113. Neurim Pharmaceuticals Ltd Business Overview
Table 114. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 115. Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 116. Neurim Pharmaceuticals Ltd Recent Development
Table 117. Pila Pharma AB Company Details
Table 118. Pila Pharma AB Business Overview
Table 119. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 120. Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 121. Pila Pharma AB Recent Development
Table 122. Sylentis SAU Company Details
Table 123. Sylentis SAU Business Overview
Table 124. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 125. Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 126. Sylentis SAU Recent Development
Table 127. Toray Industries Inc Company Details
Table 128. Toray Industries Inc Business Overview
Table 129. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 130. Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 131. Toray Industries Inc Recent Development
Table 132. Vitality Biopharma Inc Company Details
Table 133. Vitality Biopharma Inc Business Overview
Table 134. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product
Table 135. Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021) & (US$ Million)
Table 136. Vitality Biopharma Inc Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2020 VS 2027
Figure 2. CMX-020 Features
Figure 3. CA-016 Features
Figure 4. DD-04107 Features
Figure 5. Others Features
Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2020 VS 2027
Figure 7. Ophthalmology Case Studies
Figure 8. Immunology Case Studies
Figure 9. Muscle Spasm Case Studies
Figure 10. Pruritus Case Studies
Figure 11. Abdominal Pain Case Studies
Figure 12. Others Case Studies
Figure 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 Report Years Considered
Figure 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Regions: 2020 VS 2027
Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Regions (2022-2027)
Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2020
Figure 19. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue in 2020
Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2016-2021)
Figure 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2022-2027)
Figure 23. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2016-2027)
Figure 25. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2016-2027)
Figure 26. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2016-2027)
Figure 27. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2016-2027)
Figure 31. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2016-2027)
Figure 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2016-2027)
Figure 33. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2016-2027)
Figure 43. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2016-2027)
Figure 51. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2016-2027)
Figure 52. Latin America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2016-2027)
Figure 53. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2016-2027)
Figure 59. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Amgen Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 63. Amorepacific Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 64. BCN Peptides SA Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 65. Centrexion Therapeutics Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 66. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 67. DoNatur GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 68. Flex Pharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 69. Grunenthal GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 70. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 71. Medifron DBT Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 72. Neurim Pharmaceuticals Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 73. Pila Pharma AB Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 74. Sylentis SAU Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 75. Toray Industries Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 76. Vitality Biopharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Professional Survey Report 2019
QYR9NV13581 2019年11月16日 115Pages
※本調査レポートは、性受容体電位カチオンチャネルサブファミリーVメンバー1(TRPV1)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CMX-020、CA-...

性受容体電位カチオンチャネルサブファミリーVメンバー1(TRPV1)のグローバル市場調査 2019年

世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場規模・現状・予測（2021年-2027年）

Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Size, Status and Forecast 2021-2027
QFJ1-6055 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、腫瘍壊死因子受容体スーパーファミリーメンバー9の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Ultra-41BBL、PRS-342、ISAS-01、EU-101、その他）、用途別市場規模（胃がん、膀...

世界の一過性タンパク質発現市場規模・現状・予測（2021年-2027年）

Global Transient Protein Expression Market Size, Status and Forecast 2021-2027
QFJ1-4972 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、一過性タンパク質発現の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬、発現ベクター、コンピテントセル）、用途別市場規模（ゲノム研究、遺伝子治療、バイオ生産、がん研究、創薬）、主要地域別市場規...

世界の潜在的感染予防市場規模・現状・予測（2021年-2027年）

Global Potential Infection Control Market Size, Status and Forecast 2021-2027
QFJ1-4740 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、潜在的感染予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（消毒製品、滅菌製品、その他）、用途別市場規模（病院・クリニック、ライフサイエンス産業、医療機器会社、製薬会社、食品産業、その他）、主要地域...

世界のエフリンB型受容体4市場規模・現状・予測（2021年-2027年）

Global Ephrin Type B Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5725 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、エフリンB型受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VDAU-11、Vas-01、トシレートテセバチニブ、その他）、用途別市場規模（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）、...

世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 1 Market Size, Status and Forecast 2021-2027
QFJ1-5683 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）、用途別市場規模（炎症、肺がん、黒色腫、術後痛...

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年）

Global Interleukin 12 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5806 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、インターロイキン12受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）、用途別市場規模（入院患者、外来患者）、...

世界のブラジキニンB1受容体市場規模・現状・予測（2021年-2027年）

Global Bradykinin B1 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5635 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ブラジキニンB1受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BI-113823、その他）、用途別市場規模（診療所、病院、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

性受容体電位カチオンチャネルサブファミリーVメンバー1(TRPV1)のグローバル市場調査 2019年 The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transient Receptor Potential Cation Channel Subfamily V Member 1 volume an…
性受容体電位カチオンチャネルサブファミリーVメンバー1(TRPV1)のグローバル市場調査 2019年 The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transient Receptor Potential Cation Channel Subfamily V Member 1 volume an…
世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market The global Tumor Necrosis Factor Receptor Superfamily Member 9 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
世界の一過性タンパク質発現市場規模・現状・予測（2021年-2027年） Transient protein expression, that is, in the initial stage after transient transfection, the plasmid or DNA fragment is free in the cell and can be expressed, which is called transient transfection expression. Subsequently, the plasmid or DNA fragment free in the cell has two kinds of naturalizatio…
世界の潜在的感染予防市場規模・現状・予測（2021年-2027年） Potential infection control refers to the use of policies and procedures to minimize the risk of spreading infections, especially in hospitals and human or animal health care facilities. The purpose of infection control is to reduce the incidence of infectious diseases. Market Analysis and Insights:…